Blood inflammation markers and heart attack survival outcomes

Plain-English translation of NCT07026708 on ClinicalTrials.gov ↗ · Source last updated September 2025 · Translation generated June 2026 · How we translate trials

What is this trial?

Researchers are investigating whether a simple blood test called the neutrophil-to-lymphocyte ratio (NLR) can predict which heart attack patients are at higher risk of serious complications or death. This study will follow 1,600 people who have experienced a heart attack and received emergency treatment, tracking their recovery and health outcomes for six months.

Even with modern heart attack treatments, some patients still have serious complications or don't survive. Doctors need better ways to quickly identify which patients are at highest risk so they can provide extra care and monitoring early on. This blood test is inexpensive and already routinely done, but no one has fully proven whether it works as a warning sign in this population.

Do you qualify?

You likely qualify if…

you are between 18 and 85 years old
you have been diagnosed with an acute coronary syndrome (heart attack, either STEMI or NSTEMI)
you received emergency cardiac catheterization and stent placement (PCI) to open your blocked artery
you are being treated at the participating cardiology department or intensive care unit

You likely don't qualify if…

you had a heart attack but did not receive cardiac catheterization and stent placement
you died before undergoing the emergency stent procedure
you are unable or unwilling to provide a phone number for follow-up calls
you have a different heart condition instead of acute coronary syndrome

What participation looks like

If you join, researchers will collect your blood samples at three time points: when you arrive at the hospital, 24 hours after your stent placement, and 48 hours after your stent placement. These are standard tests already done for your care. Then, over the next six months, the study team will call you by phone to ask about your symptoms, chest pain, shortness of breath, and overall health and quality of life.

AI-generated summary from trial data · Jun 5, 2026 · Not medical advice

Trial locations(1 site)

Albania

Faculty of Medicine Tirana, Tirana

Key details

Sponsor

University Hospital Centre Mother Teresa

Collaborators

Charite University, Berlin, Germany

Enrollment target

~1,600 participants

Started

November 2024

Primary completion

November 2026

Age range

18 Years – 85 Years

Last updated on clinicaltrials.gov in September 2025.

Contact the research team directly

Reach out to the team running this trial. Response times vary — some teams are faster than others.

Central contact

Martiola Kola, MD

University of Medicine, Tirana

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.

View full record on ClinicalTrials.gov